Elevated TNFα induces hyperreactive platelets by reprogramming hematopoietic stem cells in mice
The inflammatory cytokine acts directly on stem cells rather than mature megakaryocytes, driving myeloid biasing and thromboinflammation through a persistent transcriptional program.
bioRxiv · Siner JI et al. · Paper published 29 Sep 2026
In mouse models, researchers investigated how chronic exposure to the inflammatory cytokine TNFα generates hyperreactive platelets. Using receptor labeling and single-cell RNA sequencing, the team found that megakaryocytes and their progenitors lack TNFα receptors. Instead, chronic TNFα expanded the hematopoietic stem and progenitor cell pool in bone marrow and extramedullary tissues. These expanded cells retained functional repopulation capacity. Activating TNFα receptor 1 signaling proved sufficient to cause platelet hyperreactivity even without progenitor cell expansion. Lineage-tracing experiments showed that chronic TNFα promoted megakaryocyte development through the canonical hematopoietic hierarchy rather than emergency hematopoiesis pathways. The exposure induced a distinct transcriptional program in stem cells and megakaryocytes that persisted through differentiation.
Why it matters
Because TNFα is a primary age-related cytokine, these findings explain how chronic inflammation can reprogram blood stem cells to promote thrombosis and thromboinflammation in aging.
Caveats
The findings are based entirely on mouse models and may not fully translate to humans. Additionally, this work is a preprint and has not yet undergone peer review.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
TNFα drives platelet hyperreactivity and thromboinflammation through regulation of hematopoietic stem and progenitor cells
Siner JI, Brakhane M, Platten K et al.
bioRxiv · 29 Sep 2026 · Preprint, not yet peer-reviewed
- Relevance
- Relevant
- News value
- Important
- Evidence
- Animals
- Status
- Preprint
More on Inflammaging
See allCranial bone marrow monocytes drive brain injury inflammation and respond to fenofibrate
Targeting PPARα deficiency in cranial bone marrow monocytes improved cognitive function and reduced neurodegeneration markers in older patients with chronic brain injury.
Science translational medicine · Lu Z et al.
Somatic blood mutations associate with accelerated frailty and functional decline in humans
In a preprint analyzing over 730,000 adults, researchers linked clonal hematopoiesis to faster physical decline mediated by T-cell changes.
medRxiv · Zhao K et al.
Impaired glymphatic clearance links inflammation to accelerated brain aging in schizophrenia
Neuroimaging and post-mortem transcriptomics connect disrupted astrocytic aquaporin-4 polarization and blood-brain barrier breakdown to increased epigenetic and brain age.
bioRxiv · Tan X et al.
ASXL1 mutations in clonal hematopoiesis accelerate aortic valve calcification
Large human cohort data and cell experiments show that ASXL1-driven clonal hematopoiesis worsens aortic valve hemodynamics and promotes calcification through inflammatory signaling.
medRxiv · Small A et al.
Loss of SATB1 alters 3D genome architecture in aged mouse T cells
Declining levels of the chromatin organizer SATB1 disrupt genomic boundaries and drive inflammatory gene activation in naive CD4+ T cells.
Science advances · Wang B et al.